Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Alpha-Linolenic Acid on Glycemic Control in Participants With Type 2 Diabetes

NCT02701894 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT02701894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02701894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Alpha-Linolenic Acid on Glycemic Control in Participants With Type 2 Diabetes
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2012
Completion date
March 31, 2016
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus